Richard Kelly – Is it possible to discontinue anticoagulation in patients with PNH?
VJHemOnc shared on X:
“Is it possible to discontinue anticoagulation in patients with PNH?
Dr Richard Kelly commented on this in a recent interview at IPIG2025, which you can watch.”
Watch the full interview on VJHemOnc to explore whether anticoagulation withdrawal is feasible—and for whom
Can anticoagulation safely be discontinued in patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)? This pressing clinical question was recently addressed by Dr. Richard Kelly during an interview at the International PNH Interest Group Congress (IPIG 2025). As treatment paradigms evolve with the advent of complement inhibitors, the traditional rationale for long-term anticoagulation in PNH patients is being actively re-evaluated”.
Dr. Kelly shares insights into emerging data, individualized risk stratification, and the potential for safe de-escalation of anticoagulant therapy in select patients with controlled hemolysis and no history of thrombosis.
You can read a wide variety of new posts in Hemostasis Today.
-
Nov 19, 2025, 18:03Andres Ricaurte Fajardo on a Strongyloides Stercoralis Hyperinfection with Thrombosis
-
Nov 19, 2025, 17:50Marilena Vrana Reflects on PPTA Europe’s Visits with Members and Stakeholders in 2025
-
Nov 19, 2025, 17:32Michael Makris Shares Insights from Global Forum Meeting of the WFH Meeting in Montreal
-
Nov 19, 2025, 17:14Yazan Abou Ismail Takes The Legacy Award from Qatar Foundation
-
Nov 19, 2025, 17:02Wolfgang Miesbach Shares Real-World Evidence on Eptacog Beta from Spain
-
Nov 19, 2025, 16:34Ishita Singh Reflects on Haematocon 2025: A Reminder of Her Commitment to The Journey
-
Nov 19, 2025, 16:23Mehdi Kashani: I’m Really Excited to Share Schistosite.com
-
Nov 19, 2025, 16:09A ”Meow-cyte” from Melaku Abay Muluneh or Why Microscopy Never Gets Old!
-
Nov 19, 2025, 15:56Cuilan Li on her Contribution to a Cutting-Edge Project in Polycythemia Vera